Tavaborole
Other Antifungals For Topical Use
- Drug class
- Other Antifungals For Topical Use
- Availability
- Prescription only
- Routes
- Topical
- Markets covered
- 1
- Products on record
- 2
- FDA reports (12 mo)
- 4
Overview
Plain-language summary, compiled from the cited regulatory records
Tavaborole is an oxaborole antifungal medication [1]. It is classified as an "Other Antifungals For Topical Use" [1]. Tavaborole is approved for the treatment of onychomycosis of the toenails [1]. The approved uses specify it is indicated for onychomycosis caused by the fungi *Trichophyton rubrum* or *Trichophyton mentagrophytes* [1].
This medication is available under various brand names [N]. In the past 12 months, there have been 4 adverse event reports associated with tavaborole [2]. Some of the top reported reactions include blister, chemical burn, cholelithiasis, drug ineffective, and ear operation [N].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 2 | September 15, 2025 |
USUnited States· FDA
2 products
Uses
1 INDICATIONS AND USAGE Tavaborole topical solution, 5% is an oxaborole antifungal indicated for the treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophyte. Tavaborole topical solution is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes .
(1)
How to take
Sources & citations
- [1]FDA DailyMed · 050f5d10-5591-42… · revised September 15, 2025 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.